This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Kringle Pharma Inc., Tohoku Techno Arch Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Kota Ishizawa: Innovator in Alveolar Cell Regeneration
Introduction
Kota Ishizawa is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the area of alveolar cell differentiation. His innovative work has the potential to impact treatments for pulmonary conditions.
Latest Patents
Ishizawa holds a patent for a differentiation- or regeneration-inducing agent for alveoli. This invention provides an agent comprising HGF (Hepatocyte Growth Factor) for inducing the differentiation of bone marrow cells into alveolar cells. The patent also addresses the use of an HGF-containing agent for promoting alveolar formation in cases of pulmonary emphysema, where alveoli are damaged.
Career Highlights
Throughout his career, Kota Ishizawa has worked with various companies, including Kringle Pharma Inc. and Tohoku Techno Arch Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of regenerative medicine.
Collaborations
Ishizawa has collaborated with notable colleagues, including Hiroshi Kubo and Hidetada Sasaki. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Kota Ishizawa is a pioneering inventor whose work in alveolar cell regeneration holds promise for future medical advancements. His contributions to regenerative medicine are noteworthy and reflect his dedication to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile